🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Glioma Glioblastoma Multiforme

Key Longitudinal Associations With Risk and Glioblastoma Outcomes NCT06625684n/a1 site📍 Durham Duke University A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment NCT05708352Phase 25 sites📍 Los Angeles📍 San Francisco📍 Santa Monica Cedars-Sinai Medical Center · Tests: Keto Diet, Standard Anti-Cancer Diet Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma NCT07538128EARLY Phase 11 site📍 Shanghai Huashan Hospital · Tests: YSCH-01, Atezolizumab (1200 mg every three weeks) Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures NCT07493447EARLY Phase 11 site📍 Nashville Eben Rosenthal · Tests: Panitumumab-IRDye800 NK Cell Therapy for Malignant Solid Brain Tumors NCT07552233NA4 sites📍 Beijing📍 Qinhuangdao📍 Zhengzhou Peking University Third Hospital · Tests: Autologous NK cells Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma NCT06419946Phase 320 sites📍 Graz📍 Innsbruck📍 Linz Vastra Gotaland Region · Tests: Temozolomide, Lomustine LITT for Ultra-early GBM Recurrence NCT07616986NA1 site📍 Bern Insel Gruppe AG, University Hospital Bern · Tests: LITT Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma NCT07067905EARLY Phase 11 site📍 Beijing Chinese PLA General Hospital · Tests: 68Ga-XT771 D2C7-IT + 2141-V11 Combination Post-resection in rGBM NCT06455605Phase 11 site📍 Durham Darell Bigner · Tests: D2C7-IT, 2141 V11 Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells NCT06059690Phase 1, Phase 21 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: pH Measurement of in vivo tissue Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression NCT06975332NA2 sites📍 Warsaw📍 Warsaw Medical University of Warsaw · Tests: Local, targeted therapy with alpha emitter [225Ac]Ac-DOTA-SP (TAT) Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma NCT07076472EARLY Phase 11 site📍 Rochester Mayo Clinic · Tests: Aminolevulinic Acid Intravenous Formulation SONALA-001, Biospecimen Collection, Computed Tomography, Electronic Health … A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients NCT06496971Phase 32 sites📍 Taipei📍 Taoyuan NaviFUS Corporation · Tests: Bevacizumab, Microbubble, Low-Intensity Focused Ultrasound A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM NCT05303467Phase 19 sites📍 Birmingham📍 San Diego📍 San Francisco Boston Scientific Corporation · Tests: TheraSphere GBM Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma NCT05281731NA1 site📍 St Louis Washington University School of Medicine · Tests: Sonobiopsy, Research blood, Cancer Personalized Profiling, Definity® Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer NCT07664579n/a1 site📍 Duarte City of Hope Medical Center · Tests: Non-Interventional Study Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma NCT04547777Phase 11 site📍 Durham Darell Bigner · Tests: D2C7-IT, 2141-V11 Imaging Acetadote Metabolism in Glioblastoma NCT07387666EARLY Phase 11 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Acetadote Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor NCT05590689Phase 1, Phase 21 site📍 Münster Universität Münster · Tests: Gliolan, Radiodynamic therapy Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma NCT07708961Phase 23 sites📍 Scottsdale📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Archive Sample Retrieval, Biospecimen Collection, Chest Radiography, Echocardiography Test, EGFR/EGFRvIII Inhibitor WSD… A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients NCT07185880Phase 1, Phase 23 sites📍 Phoenix📍 Jacksonville📍 Rochester Myosin Therapeutics Inc. · Tests: MT-125 [177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma NCT07655869EARLY Phase 12 sites📍 Beijing📍 Beijing Beijing Tiantan Hospital · Tests: [177Lu]Lu-DOTA-EB-RGD2 Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial NCT06533163NA6 sites📍 Stuttgart📍 München📍 Bonn BioTex, Inc. · Tests: Oncomagnetic device Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma NCT07464925Phase 13 sites📍 Tampa📍 Chicago📍 New York Tetragon Biosciences Ltd · Tests: GLIX1 Preoperative Preradiotherapy TTFields NCT06136611NA1 site📍 Manchester The Christie NHS Foundation Trust · Tests: TTFields Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma NCT07225621Phase 211 sites📍 Boston📍 Rochester📍 Albany Alpheus Medical, Inc. · Tests: 5-ALA HCl + LIDU SDT, Placebo + Sham SDT Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression NCT07670026Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Sintilimab, Bevacizumab, Postoperative Radiotherapy, Temozolomide Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma NCT06410248Phase 11 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Magnetic Resonance Imaging, Questionnaire Administration, Resection, Temozolomide Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning NCT05864976n/a1 site📍 St Louis Washington University School of Medicine · Tests: Support Vector Machine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy